These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28960185)

  • 1. Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?
    Jankovic J
    Nat Rev Neurol; 2017 Nov; 13(11):643-644. PubMed ID: 28960185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkinson disease. Value of COMT inhibitors is verified].
    MMW Fortschr Med; 2001 May; 143(18):51. PubMed ID: 11387711
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Exenatide a Treatment for Parkinson's Disease?
    Athauda D; Wyse R; Brundin P; Foltynie T
    J Parkinsons Dis; 2017; 7(3):451-458. PubMed ID: 28777758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post hoc analysis of the Exenatide-PD trial-Factors that predict response.
    Athauda D; Maclagan K; Budnik N; Zampedri L; Hibbert S; Aviles-Olmos I; Chowdhury K; Skene SS; Limousin P; Foltynie T
    Eur J Neurosci; 2019 Feb; 49(3):410-421. PubMed ID: 30070753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for Parkinson's disease.
    Lees AJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):607-10. PubMed ID: 12438454
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of neuroprotection for Parkinson's disease.
    LeWitt PA
    Neurology; 2004 Oct; 63(7 Suppl 2):S23-31. PubMed ID: 15477583
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease.
    Yoritaka A; Ohtsuka C; Maeda T; Hirayama M; Abe T; Watanabe H; Saiki H; Oyama G; Fukae J; Shimo Y; Hatano T; Kawajiri S; Okuma Y; Machida Y; Miwa H; Suzuki C; Kazama A; Tomiyama M; Kihara T; Hirasawa M; Shimura H; Oda E; Ito M; Ohno K; Hattori N
    Mov Disord; 2018 Sep; 33(9):1505-1507. PubMed ID: 30207619
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus.
    Scuderi MA; Ribeiro Petito M; Unniappan S; Waldner C; Mehain S; McMillian CJ; Snead EC
    Domest Anim Endocrinol; 2018 Oct; 65():80-89. PubMed ID: 30015124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson disease and growth factors - is GDNF good enough?
    Kirkeby A; Barker RA
    Nat Rev Neurol; 2019 Jun; 15(6):312-314. PubMed ID: 30948845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 13. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
    Aviles-Olmos I; Dickson J; Kefalopoulou Z; Djamshidian A; Kahan J; Ell P; Whitton P; Wyse R; Isaacs T; Lees A; Limousin P; Foltynie T
    J Parkinsons Dis; 2014; 4(3):337-44. PubMed ID: 24662192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for PD.
    Lieberman A
    Neurology; 1993 Dec; 43(12):2725-6; author reply 2726-7. PubMed ID: 8255491
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy for PD.
    Löschmann PA; Klockgether T; Schugens MM
    Neurology; 1993 Dec; 43(12):2725; author reply 2726-7. PubMed ID: 8255490
    [No Abstract]   [Full Text] [Related]  

  • 16. Transdermal selegiline (Emsam).
    Med Lett Drugs Ther; 2006 May; 48(1235):41-2. PubMed ID: 16770292
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative effects of medical therapies for Parkinson's disease.
    Horn S; Stern MB
    Neurology; 2004 Oct; 63(7 Suppl 2):S7-12. PubMed ID: 15477585
    [No Abstract]   [Full Text] [Related]  

  • 18. Pramipexole and ropinirole for Parkinson's disease.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of early Parkinson's disease.
    Marsh L; Dawson TM
    BMJ; 2000 Jul; 321(7252):1-2. PubMed ID: 10875807
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ciladopa on Parkinson's disease: a preliminary report.
    Weiner WJ; Berger JR
    Adv Neurol; 1987; 45():583-6. PubMed ID: 3548268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.